The pharmacologic treatment of Dravet syndrome.

Abstract

Dravet syndrome (DS) is one of the most pharmacoresistant epilepsy syndromes. Valproate is used as a first-line agent to prevent the recurrence of febrile seizures and oral/nasal/rectal benzodiazepine is used for any long-lasting seizures, but these agents are most often insufficient. Lamotrigine, carbamazepine, and high doses of intravenous phenobarbital… (More)
DOI: 10.1111/j.1528-1167.2011.03007.x

Topics

  • Blog articles referencing this paper

  • Presentations referencing similar topics